A Dedicated Transcatheter Heart Valve for Native Aortic Regurgitation in Patients With Significant Aortic Angulation
Percutaneous treatment options for high-risk patients with severe, symptomatic aortic regurgitation are currently limited to investigational devices. The J-Valve (JC Medical, Inc) demonstrates promising results in patients with challenging anatomies. We present 2 cases of successful transcatheter aortic valve replacement using the J-Valve in patients with significant aortic angulation.
Authors
- Zaid Alirhayim (ORCID: https://orcid.org/0009-0009-4734-615X)
- Puvi Seshiah (ORCID: https://orcid.org/0009-0007-3192-3878)
- Geoffrey A. Answini
- Santiago García (ORCID: https://orcid.org/0000-0003-3715-8082)
- Nadeen Faza (ORCID: https://orcid.org/0000-0002-0601-8741)
- Neal S. Kleiman (ORCID: https://orcid.org/0000-0002-4334-8133)
- Gustavo Mendez Hirata
- Michael Reardon (ORCID: https://orcid.org/0000-0001-8003-5227)
- Amy Simone
- Dean J. Kereiakes (ORCID: https://orcid.org/0000-0003-1086-127X)
- Sachin S. Goel (ORCID: https://orcid.org/0000-0001-6041-3876)
Institutions
- Houston Methodist (US)
- Collaborative Drug Discovery (United States) (US)
- Christ Hospital (US)
Publication Details
- Journal
- JACC Case Reports
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1016/j.jaccas.2024.102662
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00